- Conditions
- Drug; Withdrawal Symptoms, Neonatal, Withdrawal, Fetus and Newborn Affected by Other Maternal Medication
- Interventions
- BZDs + opiate exposure treated with BPN, Opiates exposure treated with BPN
- Drug
- Lead sponsor
- Gauda, Estelle B., M.D.
- Individual
- Eligibility
- Up to 7 Days
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2014
- U.S. locations
- 1
- States / cities
- St. Petersburg, Florida
Source: ClinicalTrials.gov public record
Updated May 5, 2016 · Synced May 22, 2026, 1:12 AM EDT